Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb
Produktbild: Gene Therapy of Cancer
Band 35

Gene Therapy of Cancer Methods and Protocols

Aus der Reihe Methods in Molecular Medicine

Fr. 137.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

17.02.2000

Herausgeber

Wolfgang Walther + weitere

Verlag

Humana Press

Seitenzahl

645

Maße (L/B/H)

23.5/15.5/4.1 cm

Gewicht

2 g

Auflage

2000

Sprache

Englisch

ISBN

978-0-89603-843-1

Beschreibung

Rezension

"A wide variety of methods used to deliver genes to tumors are discussed, as are the type of genes used. This includes tumor vaccination, suicide genes, antisense genes, ribozymes, etc. The unique aspect of this book is the translational approach of explaining laboratory techniques as well as the application to patients. . .This book is well written and a translational resource for those interested in the rapidly advancing and novel field of gene therapy for malignancies."-Doody's Health Science Book Review Journal

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

17.02.2000

Herausgeber

Verlag

Humana Press

Seitenzahl

645

Maße (L/B/H)

23.5/15.5/4.1 cm

Gewicht

2 g

Auflage

2000

Sprache

Englisch

ISBN

978-0-89603-843-1

Herstelleradresse

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Gene Therapy of Cancer
  • Part I. Experimental Approaches to Cancer Gene Therapy. Immunotherapy/ Tumor vaccination. Immunizing Potential of Cytokine-Transduced Tumor Cells. Particle-Mediated Gene Transfer into Dendritic Cells: A Novel Strategy for the Induction of Immune Responses against Tumor Antigens. Cancer Gene Therapy with Heat Shock Protein-65 Gene. Recombinant Vaccinia Virus MVA for Generation and Analysis of T Cell Responses Against Tumor Associated Antigens. Suicide Gene Therapy. Selection of Cytochrome P450 Genes for Use in Prodrug Activation-Based Cancer Gene Therapy. Construction of P450-Expressing Tumor Cell Lines Using Retroviruses. In Vitro Methods for Evaluation of P450-Based Anticancer Gene Therapy. Tumor Models for Evaluation of P450 Gene Therapy In Vivo. Anti-Oncogene and Suppressor Gene Therapy. Intracellular Single-Chain Antibodies for Gene Therapy. Combined Adenoviral Transfer of Tumor Suppressor and Cell-Cycle Genes for Tumor-Cell Apoptosis. Antisense Gene Therapy. Inhibition of Cell Growth by Antisense Oligonucleotides Targeting the Growth-Related Protein Kinase c-raf. IGF-1 Antisense Strategies for Cancer Treatment. Ribozyme Gene Therapy. Anti-MDR1 Ribozyme Gene Therapy. Anti-c-erbB2 Ribozyme for Gene Therapy of Breast Cancer. Anti-K-ras Ribozyme Adenoviral Vector for Gene Therapy of Non-Small Cell Lung Cancer. Delivery Systems and Tumor Targeting. Green Fluorescent Protein Retroviral Vector: Generation of High-Titer Producer Cells and Virus Supernatant. HSV-1 Vectors for Gene Therapy of Experimental CNS Tumors. Intratumoral Injection of Naked DNA. Cationic Liposome Gene Transfer. In Vivo Particle-Mediated Gene Transfer for Cancer Therapy. Gene Targeting to Hepatomas (AFP). Adenovirus-Mediated Targeted Gene Therapy for Breast Cancer and for Purging Hematopoietic Stem-Cell Sources. Chemotherapy-Inducible Vector for Gene Therapy of Cancer. Alternative Approaches in Cancer Gene Therapy. Oncolytic Adenoviral Vectors. Genetically Modified Clostridium for Gene Therapy ofTumors. Tumor-Targeted Salmonella: Strain Development and Expression of the HSV-tK Effector Gene. Part II. Clinical Protocols for Cancer Gene Therapy. Immunotherapy/Tumor Vaccination. Ex Vivo Cytokine Gene Transfer in Melanomas by Using Particle Bombardment. Intratumoral Gene Transfer of the HLA-B7 Gene Into Colon Carcinoma Metastases. Hybrid Cell Vaccination in Patients with Metastatic Melanoma. Suicide Gene Therapy. Retroviral Transfer of the Herpes Simplex Virus-Thymidine Kinase (HSV-tK) Gene for the Treatment of Cancer. Gene Therapy for Treatment of Brain Tumors (HSV-tK In Vivo Gene Transfer): A Case Study. Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tk. Intratumoral Gene Transfer of the Cytosine Deaminase Gene for the Treatment of Breast Cancer. Anti-Oncogene and Suppressor Gene Therapy. Adenovirus-Mediated Wild-Type p53 Gene Transfer into Head and Neck Cancers. Direct DNA Injection (p53) into HCC Tumors. A Phase II Trial of Intratumoral Injection with Selectively Replicating Adenovirus (ONYX-015) in Patients with Recurrent, Refractory Squamous Cell Carcinoma of the Head and Neck. Antisense Gene Therapy. c-myb Antisense Oligonucleotide Therapeutics for Hematologic Malignancies. Ovarian Cancer Gene Therapy with BRCA1- An Overview. Methods for Chemoprotection and Chemosensitization: MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors to Modify Epithelian Neoplastic Cells. Index